Qualisys (QSYS) investor relations material

Executive summary

• Q2 2026 net sales were SEK 54.4 million, down 2.4% year-over-year, but currency-adjusted sales rose 3.5%.

• Gross margin improved to 66.7% in Q2, reflecting disciplined cost control and favorable product mix.

• Adjusted EBIT rose to SEK 4.0 million from SEK 3.4 million year-over-year, with net profit at SEK 4.1 million.

• The launch of Prisma Pose, a markerless skeletal tracking solution, completed the markerless product suite and is expected to drive high-margin, capital-light revenue.

• Order intake is building, with APAC showing strong growth and momentum expected to continue into the seasonally stronger second half.

Financial highlights

• Q2 net sales: SEK 54.4 million (Q2 2025: SEK 55.7 million); currency-adjusted, up 3.5%.

• Gross margin improved to 66.7% (65.6% last year); EBIT margin rose to 7.3% (6.2%).

• First half net sales: SEK 94.4 million (down 17.7% year-over-year); EBIT margin at 0.4% (7.9%).

• Net profit for Q2: SEK 4.1 million (SEK 0.41/share); first half: SEK 0.05/share.

• Cash and cash equivalents at June 30, 2026: SEK 46.9 million.

Outlook and guidance

• Second half is historically the strongest; management targets 15% annual growth and 20% EBIT margin.

• Growing order backlog and improving macroeconomic conditions support a positive outlook.

• Focus remains on capturing new business in emerging markets and converting pipeline into orders.

• Macroeconomic improvements anticipated to support performance in coming quarters.